Pharma News for the week of March 23, 2020

 

Pfizer has paused enrollment in many new and ongoing clinical trials in response to the COVID-19 pandemic, Reuters reports. The action sees Pfizer join Bristol Myers Squibb and Eli Lilly on the list of Big Pharma companies to revise their R&D plans in light of the novel SARS-CoV-2 coronavirus. (Fiercebiotech)

The U.K. government has backed a University of Oxford effort to develop a vaccine against COVID-19. Officials handed out the cash to help Sarah Gilbert’s team deliver on its plans to get a vaccine against the novel coronavirus into clinical testing next month. (Fiercebiotech)

“Would this possibly become a seasonal cyclic thing? I’ve always indicated to you that I think it very well might,” Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, said in a White House press briefing. (CNBC)

Consumers should beware of buying or using products that sellers claim will help diagnose, treat, cure or prevent COVID-19 as the coronavirus continues to sweep across the country, the U.S. Food and Drug Administration said Wednesday. (CNBC)

The CDC normally takes the lead in outbreaks, ranging from the 2009 flu pandemic to Ebola to the lung injuries caused by vaping. Its recent absence from the national stage has led to fears that the agency’s objective, science-based approach is being ignored, especially as Trump signals that he hopes to relax restrictions on social gatherings by Easter to help revive the economy. (NPR)

en_USEnglish
en_USEnglish